These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36406896)

  • 1. Assessment of dd-cfDNA Levels in Clinically Stable Lung Allograft Recipients Beyond the Initial 2 y Posttransplant.
    Trindade AJ; Chapin KC; Mullican A; Gray JN; Hoy H; Demarest CT; Lambright ES; McPherson KA; Norfolk SG; Robbins IM; Bacchetta M; Erasmus DB; Shaver CM
    Transplant Direct; 2022 Dec; 8(12):e1411. PubMed ID: 36406896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of plasma donor-derived cell free DNA for lung allograft rejection diagnosis in lung transplant recipients.
    Ju C; Xu X; Zhang J; Chen A; Lian Q; Liu F; Liu H; Cai Y; Zou Y; Yang Y; Zhou Y; He J
    BMC Pulm Med; 2023 Jan; 23(1):37. PubMed ID: 36703125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Validation of a Plasma Donor-derived Cell-free DNA Assay to Detect Allograft Rejection and Injury in Lung Transplant.
    Rosenheck JP; Ross DJ; Botros M; Wong A; Sternberg J; Chen YA; Liang N; Baer A; Ahmed E; Swenerton R; Zimmermann BG; Fehringer G; Demko ZP; Olymbios M; Billings PR; Keller BC
    Transplant Direct; 2022 Apr; 8(4):e1317. PubMed ID: 35372675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative Change in Donor-Derived Cell-free DNA is Superior to Absolute Values for Diagnosis of Acute Lung Allograft Dysfunction.
    Trindade AJ; Chapin KC; Gray JN; Furuya Y; Mullican A; Hoy H; Demarest CT; Robbins IM; Bacchetta M; Erasmus DB; Shaver CM
    Transplant Direct; 2023 Jun; 9(6):e1487. PubMed ID: 37250487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor-derived, cell-free DNA levels by next-generation targeted sequencing are elevated in allograft rejection after lung transplantation.
    Khush KK; De Vlaminck I; Luikart H; Ross DJ; Nicolls MR
    ERJ Open Res; 2021 Jan; 7(1):. PubMed ID: 33532456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-derived cell-free DNA as a composite marker of acute lung allograft dysfunction in clinical care.
    Keller M; Sun J; Mutebi C; Shah P; Levine D; Aryal S; Iacono A; Timofte I; Mathew J; Varghese A; Giner C; Agbor-Enoh S
    J Heart Lung Transplant; 2022 Apr; 41(4):458-466. PubMed ID: 35063338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological Variation of Donor-Derived Cell-Free DNA in Stable Lung Transplant Recipients.
    Keller M; Mutebi C; Shah P; Levine D; Aryal S; Iacono A; Timofte I; Mathew J; Varghese A; Giner C; Agbor-Enoh S
    J Appl Lab Med; 2022 Jun; 7(4):901-909. PubMed ID: 35024828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of methods for donor-derived cell-free DNA quantification in plasma and urine from solid organ transplant recipients.
    Kueng N; Arcioni S; Sandberg F; Kuhn C; Banz V; Largiadèr CR; Sidler D; Amstutz U
    Front Genet; 2023; 14():1089830. PubMed ID: 36777723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor-derived Cell-free DNA Complements De Novo Class II DSA in Detecting Late Alloimmune Injury Post Kidney Transplantation.
    Butiu M; Obrisca B; Sibulesky L; Bakthavatsalam R; Smith KD; Gimferrer I; Warner P; Ismail G; Leca N
    Transplant Direct; 2022 Feb; 8(2):e1285. PubMed ID: 35187211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transition of Renal Patients Using AlloSure Into Community Kidney Care (TRACK): Protocol for Long-Term Allograft Surveillance in Renal Transplant Recipients.
    Dale BL; Bose S; Kuo S; Burns A; Daou P; Short J; Miles J
    JMIR Res Protoc; 2021 Mar; 10(3):e25941. PubMed ID: 33720033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of donor-derived cell-free DNA between single versus double lung transplant recipients.
    Keller MB; Meda R; Fu S; Yu K; Jang MK; Charya A; Berry GJ; Marboe CC; Kong H; Luikart H; Ponor IL; Shah PD; Khush KK; Nathan SD; Agbor-Enoh S
    Am J Transplant; 2022 Oct; 22(10):2451-2457. PubMed ID: 35322546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extreme elevations of donor-derived cell-free DNA increases the risk of chronic lung allograft dysfunction and death, even without clinical manifestations of disease.
    Keller MB; Newman D; Alnababteh M; Ponor L; Shah P; Mathew J; Kong H; Andargie T; Park W; Charya A; Luikart H; Aryal S; Nathan SD; Orens JB; Khush KK; Jang M; Agbor-Enoh S
    J Heart Lung Transplant; 2024 Sep; 43(9):1374-1382. PubMed ID: 38705500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining donor-derived cell-free DNA and donor specific antibody testing as non-invasive biomarkers for rejection in kidney transplantation.
    Obrișcă B; Butiu M; Sibulesky L; Bakthavatsalam R; Smith KD; Gimferrer I; Warner P; Ismail G; Leca N
    Sci Rep; 2022 Sep; 12(1):15061. PubMed ID: 36064740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological Variation of Donor-Derived Cell-Free DNA in Renal Transplant Recipients: Clinical Implications.
    Bromberg JS; Brennan DC; Poggio E; Bunnapradist S; Langone A; Sood P; Matas AJ; Mannon RB; Mehta S; Sharfuddin A; Fischbach B; Narayanan M; Jordan SC; Cohen DJ; Zaky ZS; Hiller D; Woodward RN; Grskovic M; Sninsky JJ; Yee JP; Bloom RD
    J Appl Lab Med; 2017 Nov; 2(3):309-321. PubMed ID: 33636851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Initial Analysis of the Baseline Levels of Dd-cfDNA After Pancreas Transplantation: A Prospective Study From High-volume Centers in the United States.
    Yoo A; Riedel A; Qian I; Bartosic A; Soltani R; Kibria G; Haririan A; Drachenberg CB; Abrams PL; Odorico JS; Cooper M; Bromberg JS; Scalea JR
    Transplant Direct; 2023 Apr; 9(4):e1459. PubMed ID: 36935870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathologist interrater reliability and clinical implications of elevated donor-derived cell-free DNA beyond heart transplant rejection, on behalf of the GRAfT investigators.
    Mehta A; Goldberg J; Bagchi P; Marboe C; Shah KB; Najjar SS; Hsu S; Rodrigo ME; Jang MK; Cochrane A; Tchoukina IF; Kong H; Lohmar BJ; Mcnair E; Valantine HA; Agbor-Enoh S; Berry GJ; Shah P
    J Heart Lung Transplant; 2024 Oct; ():. PubMed ID: 39424014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-free DNA in lung transplantation: research tool or clinical workhorse?
    Keller M; Agbor-Enoh S
    Curr Opin Organ Transplant; 2022 Jun; 27(3):177-183. PubMed ID: 35649108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of Usefulness of Donor-Derived Cell-Free DNA as a Biomarker for Cardiac Allograft Vasculopathy: A Prospective Study.
    Jiménez-Blanco Bravo M; Pérez-Gómez L; Hernández-Pérez FJ; Arellano-Serrano C; Torres-Sanabria M; Gómez-Bueno M; Oteo-Domínguez JF; Mingo-Santos S; Segovia-Cubero J
    Front Cardiovasc Med; 2022; 9():856600. PubMed ID: 35463750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft-derived Cell-free DNA as a Noninvasive Biomarker of Cardiac Allograft Rejection: A Cohort Study on Clinical Validity and Confounding Factors.
    Knüttgen F; Beck J; Dittrich M; Oellerich M; Zittermann A; Schulz U; Fuchs U; Knabbe C; Schütz E; Gummert J; Birschmann I
    Transplantation; 2022 Mar; 106(3):615-622. PubMed ID: 33653997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher Molecular Injury at Diagnosis of Acute Cellular Rejection Increases the Risk of Lung Allograft Failure: A Clinical Trial.
    Keller MB; Tian X; Jang MK; Meda R; Charya A; Berry GJ; Marboe CC; Kong H; Ponor IL; Aryal S; Orens JB; Shah PD; Nathan SD; Agbor-Enoh S
    Am J Respir Crit Care Med; 2024 May; 209(10):1238-1245. PubMed ID: 38190701
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.